Literature DB >> 23901889

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

K Van der Weerd1, P M Van Hagen, B Schrijver, D J Kwekkeboom, W W De Herder, M R J Ten Broek, P T E Postema, J J M Van Dongen, F J T Staal, W A Dik.   

Abstract

Graves' disease (GD) is an autoimmune disease that involves aberrant B and T lymphocyte responses. Detailed knowledge about lymphocyte subpopulation composition will therefore enhance our understanding of the pathogenesis of GD and might support the development of new immunomodulatory treatment approaches. The aim of this study was to gain detailed insight into the composition of the peripheral blood lymphocyte compartment in GD before and during anti-thyroid drug therapy. Major B and T lymphocyte subpopulations were investigated by flow cytometry in peripheral blood from newly diagnosed GD patients (n = 5), GD patients treated with anti-thyroid drugs (n = 4), patients with recurrent GD (n = 7) and healthy controls (HC; n = 10). In GD patients, numbers of activated T lymphocytes [human leucocyte antigen D-related (HLA-DR)⁺ and CD25⁺] were increased. The B lymphocyte compartment in GD was characterized by significantly higher numbers of transitional (CD38(high) CD27⁻, P < 0.03) and pre-naive mature (CD38(low) CD27⁻ IgD⁺ CD5⁺, P < 0.04) B lymphocytes, while memory populations were slightly decreased. The increased numbers of CD5⁺, transitional and pre-naive mature B lymphocytes correlated positively with fT4 plasma levels. GD is associated with increased numbers of activated T lymphocytes and transitional and pre-naive mature CD5⁺ B lymphocytes within the peripheral blood. The increase in CD5⁺ B lymphocytes was due mainly to an increase in transitional and pre-naive mature B lymphocytes. Increased fT4 plasma levels might be associated with this increase in transitional and pre-naive mature CD5⁺ B lymphocytes.
© 2013 British Society for Immunology.

Entities:  

Keywords:  B lymphocytes; Graves' disease; T lymphocytes

Mesh:

Substances:

Year:  2013        PMID: 23901889      PMCID: PMC3828829          DOI: 10.1111/cei.12183

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.

Authors:  A Gessl; W Waldhäusl
Journal:  Clin Immunol Immunopathol       Date:  1998-05

2.  Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease.

Authors:  C Roura-Mir; M Catálfamo; M Sospedra; L Alcalde; R Pujol-Borrell; D Jaraquemada
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

3.  Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis.

Authors:  E Montecino-Rodriguez; R G Clark; L Powell-Braxton; K Dorshkind
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.

Authors:  Guia Vannucchi; Danila Covelli; Nicola Currò; Davide Dazzi; Antonia Maffini; Irene Campi; Paola Bonara; Claudio Guastella; Lorenzo Pignataro; Roberto Ratiglia; Paolo Beck-Peccoz; Mario Salvi
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

5.  Undetectable serum IgA and low IgM concentration in children with congenital hypothyroidism.

Authors:  Stefano Stagi; Chiara Azzari; Giuseppe Bindi; Fiorella Galluzzi; Sergio Nanni; Roberto Salti; Alberto Vierucci
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

6.  Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  Y Hidaka; M Okumura; Y Shimaoka; K Takeoka; H Tada; N Amino
Journal:  Thyroid       Date:  1998-03       Impact factor: 6.568

7.  Identification and characterization of circulating human transitional B cells.

Authors:  Gary P Sims; Rachel Ettinger; Yuko Shirota; Cheryl H Yarboro; Gabor G Illei; Peter E Lipsky
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

8.  Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus.

Authors:  M Murakami; Y Hosoi; T Negishi; Y Kamiya; K Miyashita; M Yamada; T Iriuchijima; H Yokoo; I Yoshida; Y Tsushima; M Mori
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

9.  Activated naive CD4+ peripheral blood T cells in autoimmune thyroid disease.

Authors:  A Gessl; A Wilfing; H Agis; G Steiner; S Czernin; G Boltz-Nitulescu; H Vierhapper; W Waldhäusl
Journal:  Thyroid       Date:  1995-04       Impact factor: 6.568

10.  Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.

Authors:  N Ishikawa; K Eguchi; Y Ueki; M Nakashima; H Shimada; K Ito; S Nagataki
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

View more
  5 in total

1.  High neutrophil-to-lymphocyte ratio is associated with relapse in Graves' disease after antithyroid drug therapy.

Authors:  Mijin Kim; Bo Hyun Kim; Min Hee Jang; Jeong Mi Kim; Eun Heui Kim; Yun Kyung Jeon; Sang Soo Kim; In Joo Kim
Journal:  Endocrine       Date:  2019-11-20       Impact factor: 3.633

2.  A genome-wide functional genomics approach uncovers genetic determinants of immune phenotypes in type 1 diabetes.

Authors:  Xiaojing Chu; Anna W M Janssen; Hans Koenen; Linzhung Chang; Xuehui He; Irma Joosten; Rinke Stienstra; Yunus Kuijpers; Cisca Wijmenga; Cheng-Jian Xu; Mihai G Netea; Cees J Tack; Yang Li
Journal:  Elife       Date:  2022-05-31       Impact factor: 8.713

3.  Microarray profile of B cells from Graves' disease patients reveals biomarkers of proliferation.

Authors:  Xuechao Jiang; Yonghui Wang; Xiaoying Li; Leqi He; Qian Yang; Wei Wang; Jun Liu; Bingbing Zha
Journal:  Endocr Connect       Date:  2020-05-01       Impact factor: 3.335

4.  Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia.

Authors:  Yang Zhao; Yihao Wang; Hui Liu; Kai Ding; Chunyan Liu; Hong Yu; Zonghong Shao; Rong Fu
Journal:  J Immunol Res       Date:  2020-02-17       Impact factor: 4.818

5.  Blood Count-derived Immunoinflammatory Markers in Thyroidassociated Ophthalmopathy.

Authors:  Volkan Yeter; Nurullah Koçak; Mehmet Tayfun Arslan; Elif Kiliç Kan
Journal:  Korean J Ophthalmol       Date:  2021-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.